TELA Bio Statistics
Share Statistics
TELA Bio has 39.39M shares outstanding. The number of shares has increased by 0.92% in one year.
| Shares Outstanding | 39.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.24% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 30.76M |
| Failed to Deliver (FTD) Shares | 246 |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 478.72K, so 1.22% of the outstanding shares have been sold short.
| Short Interest | 478.72K |
| Short % of Shares Out | 1.22% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 1.74 |
Valuation Ratios
The PE ratio is -3.24 and the forward PE ratio is -4.57.
| PE Ratio | -3.24 |
| Forward PE | -4.57 |
| PS Ratio | 2.59 |
| Forward PS | 1.2 |
| PB Ratio | 8.02 |
| P/FCF Ratio | -3.65 |
| PEG Ratio | n/a |
Enterprise Valuation
TELA Bio Inc. has an Enterprise Value (EV) of 147.44M.
| EV / Earnings | -3.16 |
| EV / Sales | 2.52 |
| EV / EBITDA | -3.63 |
| EV / EBIT | -3.35 |
| EV / FCF | -3.56 |
Financial Position
The company has a current ratio of 4.23, with a Debt / Equity ratio of 2.15.
| Current Ratio | 4.23 |
| Quick Ratio | 3.45 |
| Debt / Equity | 2.15 |
| Total Debt / Capitalization | 68.21 |
| Cash Flow / Debt | -1.01 |
| Interest Coverage | -8.44 |
Financial Efficiency
Return on equity (ROE) is -2.47% and return on capital (ROIC) is -73.51%.
| Return on Equity (ROE) | -2.47% |
| Return on Assets (ROA) | -0.6% |
| Return on Capital (ROIC) | -73.51% |
| Revenue Per Employee | 257.50K |
| Profits Per Employee | -205.57K |
| Employee Count | 227 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -51.56% in the last 52 weeks. The beta is 0.97, so TELA Bio 's price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | -51.56% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 4.14 |
| Relative Strength Index (RSI) | 46.2 |
| Average Volume (20 Days) | 221.45K |
Income Statement
In the last 12 months, TELA Bio had revenue of $58.45M and earned -$46.66M in profits. Earnings per share was $-2.04.
| Revenue | 58.45M |
| Gross Profit | 40.11M |
| Operating Income | -44.08M |
| Net Income | -46.66M |
| EBITDA | -40.63M |
| EBIT | -44.08M |
| Earnings Per Share (EPS) | -2.04 |
Balance Sheet
The company has $46.73M in cash and $41.08M in debt, giving a net cash position of $5.65M.
| Cash & Cash Equivalents | 46.73M |
| Total Debt | 41.08M |
| Net Cash | 5.65M |
| Retained Earnings | -320.89M |
| Total Assets | 53.02M |
| Working Capital | 27.27M |
Cash Flow
In the last 12 months, operating cash flow was -$40.86M and capital expenditures -$611.00K, giving a free cash flow of -$41.47M.
| Operating Cash Flow | -40.86M |
| Capital Expenditures | -611.00K |
| Free Cash Flow | -41.47M |
| FCF Per Share | -1.81 |
Margins
Gross margin is 68.62%, with operating and profit margins of -75.4% and -79.83%.
| Gross Margin | 68.62% |
| Operating Margin | -75.4% |
| Pretax Margin | -79.83% |
| Profit Margin | -79.83% |
| EBITDA Margin | -69.51% |
| EBIT Margin | -75.4% |
| FCF Margin | -70.94% |
Dividends & Yields
TELA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -73.12% |
| FCF Yield | -37.73% |
Analyst Forecast
The average price target for TELA is $10, which is 258.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 258.4% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -8.44 |
| Piotroski F-Score | 1 |